# Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients

> **NCT06217887** · NA · UNKNOWN · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 58 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus
- Cognitive Function Abnormal

## Interventions

- **DRUG:** loxenatide Group
- **DRUG:** Gliclazide Group

## Key facts

- **NCT ID:** NCT06217887
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-10
- **Primary completion:** 2024-02
- **Final completion:** 2024-06
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06217887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06217887, "Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06217887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*